• No results found

Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis

N/A
N/A
Protected

Academic year: 2020

Share "Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

References

Related documents

This paper proposes the Reversible texture synthesis for data security. The source texture is given and the scheme produces the stego synthetic texture can hiding the secret

This study shows that companies issuing equity in periods of high activity in the equity capital market (HOT markets) on average have a worse risk-adjusted abnormal stock

The term ‘‘lymphedema’’ has historically been defined as edema, which develops as a result of failure of lymphatic drainage either through problems in lymphatic development

Figure 6 indicates that the survival time of the myocardium implanted in the mice treated with 1.43, 0.143, and 0.0143 µ mol/kg/d of RGDF-Dex is 13.8, 12.3, and 9.9

We performed virtual screening of the complete Human Metabolite Database (HMDB) for docking to the multiple sclerosis (MS) susceptible DRB1*15:01 allele and compared the results

NIGHT SHOW MUSIC: All Bodybuilders, Womens Physique & Mens Classic Physique You MUST EMAIL your 60 second posing music in a MP3, M4A or WAV file (NO OBSCENITIES ALLOWED!) Email

Roscommon County Hospital had one day per week from an NCHD (also with a special interest in palliative care). Based on the NACPC report guidelines, the former Western Health